Table 3 The comparison between different treatment groups
TNF-inhibitors (n = 43) | cDMARD (n = 18) | p-value | |
|---|---|---|---|
Age (years) | 43 ± 9 | 34 ± 9 | 0.02 |
ESR (mm/hr) | 14 [8–35] | 21 [9–34] | 0.72 |
CRP (mg/L) | 2 [2–9] | 4.4 [2–10] | 0.61 |
Subfatin (ng/mL) | 0.57 [0.4–0.8] | 0.89 [0.6–1.7] | 0.03 |
CTHRC1 (ng/mL) | 54 [39–89] | 71 [40–181] | 0.33 |
CTRP3 (ng/mL) | 1.9 [1.7-2] | 2.2 [1.8-3] | 0.03 |
CTRP6 (ng/mL) | 1.92 [1.1–2.6] | 2.85 [1.5–6.8] | 0.03 |
IL-6 (pg/mL) | 70 [55–80] | 73 [55–138] | 0.35 |
IL-17 (pg/mL) | 19 [15–32] | 33 [21–55] | 0.04 |
TNF-α (pg/mL) | 93 [76–128] | 118 [97–163] | 0.01 |
ASDAS-CRP | 2.4 ± 1.0 | 2.8 ± 0.9 | 0.16 |
BASDAI | 3.4 ± 1.8 | 4.1 ± 1.7 | 0.21 |